期刊文献+

芪参益气滴丸及其组成中药抗缺血再灌注损伤的研究进展 被引量:10

Progress of Qishenyiqi Dripping Pill on Clinical and Experiment Study
下载PDF
导出
摘要 目的:了解芪参益气滴丸临床和实验研究概况,为深入研究该方作用机制提供借鉴。方法:检索芪参益气滴丸的临床和实验文献,以及芪参益气滴丸组成中药对心肌缺血再灌注损伤作用的文献,归纳总结芪参益气滴丸主要临床作用及可能的药理机制与配伍规律。结果:芪参益气滴丸临床主要应用于多种心血管疾病的治疗,并获得较好的临床疗效,少量报道应用于特发性肺纤维化、慢性乙型肝炎等治疗;药理机制的研究主要集中在以急性心肌缺血为动物模型进行研究;芪参益气滴丸4味配伍中药单独应用对心肌缺血再灌注损伤模型均有一定影响,并有一些相似的分子生物学机制。结论:芪参益气滴丸临床对多种心血管疾病确有疗效,其作用机制研究也取得了一定进展,但仍有很多不确定的地方需要深入研究。 Object:To Comprehend Progress of Qishenyiqi Dripping Pill on Clinical and Experiment Study for lucubrating its mechanism of action.Methods: Summary of main clinical effect and pharmacological mechanism and combinative regularity of Qishenyiqi formula on Cardiac ischemia and reperfusion through documents study.Result: Qishenyiqi Dripping Pill is applied to treat diverse cardiovascular diseases,gain better clinical effect,a few report about treating idiopathic pulmonary fibrosis,Chronic Hepatitis B and so on.The animal model for its pharmacological mechanism study is main acute myocardium ischemia.The four components of Qishenyiqi Dripping Pill have also some influence to the model of myocardium ischemia reperfusion injury.There are some similar molecular biology mechanism.Conclusion: Qishenyiqi Dripping Pill have certain therapeutic effect to diverse cardiovascular diseases.There are a certainly progress on its mechanism,but still to remain many uncertainly points need to evolve more deeply research.
出处 《江西中医学院学报》 2011年第3期95-100,共6页 Journal of Jiangxi College of Traditional Chinese Medicine
关键词 芪参益气滴丸 黄芪 丹参 三七 降香 心肌缺血再灌注损伤 综述 Qishenyiqi Dripping Pill Radix Astragali Mongolici Radix Salviae Miltiorrhizae Radix Notoginseng Lignum Dallbergiae Odoriferae Myocardium ischemia reperfusion injury Review
  • 相关文献

参考文献74

二级参考文献460

共引文献730

同被引文献80

  • 1DAN-YANGLI,KUIZHAO,JUN-FUZHOU,PENGCHEN,WEILI.Changes of Expressions of VEGF, bFGF, and Angiogenesis, and Effect of Benazepril, bFGF on Angiogenesis in Acute Myocardial Infarction Model of the Rabbits[J].Biomedical and Environmental Sciences,2004,17(4):442-451. 被引量:12
  • 2杨志刚,陈阿琴,俞颂东.三七药理研究新进展[J].上海中医药杂志,2005,39(4):59-62. 被引量:224
  • 3黄席珍.慢性充血性心力衰竭与睡眠呼吸障碍研究的进展[J].医学研究通讯,2005,34(11):4-6. 被引量:1
  • 4李树英.黄芪益气作用机制的探讨[J].新中医,1987,10(11):51.
  • 5郑筱萸.中药新药f临床研究指导原则[S].北京:中国医药科技出版社,2002:77-85.
  • 6Lee DC, Johnson RA, John B, et al. Heart failure in outPatients [ J ]. New England J M ed, 1982,12 (306) :699 - 705.
  • 7Jing Yan Han, Jing Yu Fan, Yoshinori Horie, et al. Ameliorating effects of comPounds derived from Salvia mihiorrhiza root extract on Microcirculatory disturbance and target organ injury by ischemia and rePerfusion [ J ]. Pharmacol Ther,2008 ( 117 ) :280 - 295.
  • 8Faux MC,Coates JL, Kershaw NJ, et al. Independentinteractions of phosphorylated B-catenin with E-cadher-in at cell-cell contacts and APC at cell protrusions [J].PLoS One, 2014 ,5(11) : 14 127-14 131.
  • 9Li LY,Chen MH, Tong TJ,et al. The molecular ba-sis of Chinese herbs (Astragali and Angelica ) on in-creasing serum album in synthesis in nephrotic rats[J].Nephrology,2013 ’4(56) : 373-378.
  • 10Nath KA, Norby SM. Reactive oxygen species and a-cute renal failure[J]. Am J Med,2010 , 109(8) : 665-678.

引证文献10

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部